For citations:

Eliseev MS, Zhelyabina OV, Mukagova MV, Nasonov EL. Clinical experience with the interleukin-1β blocker canakinumab in patients with chronic tophaceous gout: abolishment of arthritis and prevention of exacerbations when allopurinol is used. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2015;9(2):16-22. (In Russ.) https://doi.org/10.14412/1996-7012-2015-2-16-22